SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-021667
Filing Date
2020-01-31
Accepted
2020-01-31 17:21:03
Documents
3
Period of Report
2020-03-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A d881850dpre14a.htm PRE 14A 158567
2 GRAPHIC g881850img01.jpg GRAPHIC 175280
3 GRAPHIC g881850img02.jpg GRAPHIC 240515
  Complete submission text file 0001193125-20-021667.txt   732387
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 20566062
SIC: 2834 Pharmaceutical Preparations